… risk, non-metastatic prostate cancer patients most likely … of men with advanced prostate cancer,” said Nick James, … standard treatment alone – hormone therapy and radiotherapy.” About Artera … for patients with localized prostate cancer: ArteraAI Prostate Test. …

… with metastatic castration-sensitive prostate cancer with homologous recombination repair … cancer is still sensitive to hormone therapy, unlike mCRPC. Results from … with metastatic hormone-sensitive prostate cancer and homologous recombination repair …

… hormonal therapy, is effective in slowing cancer growth among men with prostate cancer … prostate cancer. At the CURE Educated Patient Prostate Cancer … Being Proactive in Prostate Cancer Care Morgans highlighted … among men with prostate cancer, stemming from …

… include Pluvicto in addition to hormone therapy. This finding is important, … progression from metastatic hormone-sensitive prostate cancer to castration-resistant disease  … PSMA-positive metastatic castration-resistant prostate cancer. The specifics of these …

… prostate cancer (nmCRPC) Metastatic castration-sensitive prostate cancer (mCSPC) Metastatic castration-sensitive prostate cancer … Sensitive Prostate Cancer Prostate cancer is … with hormone therapy, such … castration sensitive prostate cancer: optimizing …

… Zytiga. Akeega, along with hormone therapy, kept men with so … longer than Zytiga and hormone therapy, reducing the relative risk … disease stops responding to hormone therapy if they have BRCA … rights to niraparib in prostate cancer specifically, allowing it to …

… for prostate cancer include: • Age. Prostate cancer risk rises … What does prostate cancer screening involve? Prostate cancer screening starts … “About 20% of prostate cancers have a normal … prostate cancer • For advanced (stage 4) cancers, hormone therapy …

… conversation with Eric Morrow, a prostate cancer survivor, US Air Force veteran … and volunteer advocate for Zero Prostate Cancer, a nonprofit focused on supporting … involving surgery, radiation therapy, and hormone therapy to turn off testosterone production …

… patients with advanced prostate cancer Final clinical data … patients with metastatic prostate cancer Results support recent … resistant prostate cancer (mCRPC) or who had refused hormone therapy, … metastatic castration-resistant prostate cancer (mCRPC), is …

… of a certain type of prostate cancer, raising the prospect of treatment … patients with metastatic prostate cancer that still responds to standard hormone therapy. Almost all … that no longer responds to hormone therapy, a setting where Pluvicto is …